Statistical reporting of clinical pharmacology research
- PMID: 28321897
- PMCID: PMC5427231
- DOI: 10.1111/bcp.13254
Statistical reporting of clinical pharmacology research
Abstract
Research in clinical pharmacology covers a wide range of experiments, trials and investigations: clinical trials, systematic reviews and meta-analyses of drug usage after market approval, the investigation of pharmacokinetic-pharmacodynamic relationships, the search for mechanisms of action or for potential signals for efficacy and safety using biomarkers. Often these investigations are exploratory in nature, which has implications for the way the data should be analysed and presented. Here we summarize some of the statistical issues that are of particular importance in clinical pharmacology research.
Keywords: clinical pharmacology; confirmatory statistics; exploratory statistics; meta-analyses; randomized clinical trials.
© 2017 The British Pharmacological Society.
References
-
- Sheiner LB. Learning versus confirming in clinical drug development. Clin Pharmacol Ther 1997; 61: 275–291. - PubMed
-
- Wasserstein RL, Lazar NA. The ASA's statement on p‐values: context, process, and purpose. Am Statistician 2016; 70: 129–133.
-
- CHMP 2010 – Guideline on the investigation of bioequivalence. CPMP/EWP/QWP/1401/98 Rev. 1/Corr
-
- Julious SA, Debarnot CA. Why are pharmacokinetic data summarized by arithmetic means? J Biopharm Stat 2000; 10: 55–71. - PubMed
-
- Smith B. Statistical guide for clinical pharmacology & therapeutics. Clin Pharmacol Ther 2010; 88: 150–152. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources